Breaking News, Financial News

4Q Financial Reports: Abbott

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Abbott 4Q Revenues: $6 billion (+7%) 4Q Earnings: $976 million (flat) FY Revenues: $22.3 billion (+13.5%) FY Earnings: $3.4 billion (+4%) Comments: Abbott achieved records sales for the quarter and the year. Pharmaceutical Products Group sales grew 10% in the quarter, driven by performance of Humira and contributions from TriCor and Omnicef. Worldwide sales of Humira were $1.4 billion for the year, up 64%. R&D spend was up 7% for the year to $1.8 billion....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters